FDA raises several concerns with Emergent BioSolutions following inspection
FDA Completes Inspection Of J&J Vaccine Maker Emergent BioSolutions, Cites Concerns Over Cross-Contamination, Sanitation
The U.S. Food and Drug Administration has completed its inspection of the Baltimore-based Johnson & Johnson vaccine maker Emergent..
WJZ Baltimore